Addus HomeCare (NASDAQ:ADUS) EVP Sells $37,499.00 in Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Cliff Donald Blessing sold 350 shares of the business’s stock in a transaction dated Tuesday, February 24th. The shares were sold at an average price of $107.14, for a total transaction of $37,499.00. Following the completion of the sale, the executive vice president owned 12,538 shares in the company, valued at approximately $1,343,321.32. This trade represents a 2.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Cliff Donald Blessing also recently made the following trade(s):

• On Wednesday, February 25th, Cliff Donald Blessing sold 177 shares of Addus HomeCare stock. The shares were sold at an average price of $105.36, for a total transaction of $18,648.72.

Addus HomeCare Trading Down 0.5%

Shares of ADUS stock opened at $103.53 on Friday. Addus HomeCare Corporation has a 1-year low of $88.96 and a 1-year high of $124.43. The firm has a market cap of $1.92 billion, a PE ratio of 19.87, a price-to-earnings-growth ratio of 1.44 and a beta of 0.91. The company has a 50-day moving average of $109.22 and a two-hundred day moving average of $112.95. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.80 and a quick ratio of 1.66.

Key Stories Impacting Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Large institutional holders have been adding to positions in recent quarters, which provides a steady shareholder base and underlying demand. MarketBeat ADUS Institutional Holdings
• Positive Sentiment: Stephens kept an “Overweight” rating on ADUS and a $135 price target (trimmed from $140), signaling continued analyst conviction even after the cut. That backing can limit downside over the medium term. Stephens PT story
• Neutral Sentiment: Short‑interest figures are inconsistent across feeds (some reports show zero or NaN, others show a material rise). This data noise makes it hard to interpret immediate short pressure — confirm with FINRA/exchange data before acting. MarketBeat short interest
• Negative Sentiment: Significant insider selling across Feb. 24–25: CEO R. Dirk Allison and multiple EVPs sold several thousand shares in aggregate (CEO filings disclosed to the SEC). Large, concentrated insider sales are weighing on sentiment and likely contributed to today’s weakness. CEO SEC filing
• Negative Sentiment: Media flagged a “pessimistic forecast” narrative after Stephens trimmed its target, which can reinforce short‑term selling despite the retained Overweight rating. That coverage likely amplified intra‑day pressure. AmericanBankingNews piece
• Negative Sentiment: Smaller insider sales (e.g., EVP Cliff Blessing) were also reported; while individually minor, the wave of coordinated filings increases headline risk and may trigger mechanical selling. InsiderTrades alert

Institutional Investors Weigh In On Addus HomeCare

Hedge funds have recently bought and sold shares of the stock. Capital Research Global Investors boosted its stake in shares of Addus HomeCare by 22.3% in the 4th quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock valued at $157,837,000 after buying an additional 268,192 shares during the period. Tributary Capital Management LLC increased its stake in shares of Addus HomeCare by 114.1% during the third quarter. Tributary Capital Management LLC now owns 398,122 shares of the company’s stock worth $46,974,000 after buying an additional 212,192 shares during the period. Freestone Grove Partners LP raised its holdings in Addus HomeCare by 5,035.2% in the fourth quarter. Freestone Grove Partners LP now owns 137,932 shares of the company’s stock valued at $14,813,000 after acquiring an additional 135,246 shares in the last quarter. 8 Knots Management LLC purchased a new position in Addus HomeCare in the third quarter worth approximately $6,075,000. Finally, TimesSquare Capital Management LLC grew its holdings in Addus HomeCare by 13.9% during the 2nd quarter. TimesSquare Capital Management LLC now owns 394,047 shares of the company’s stock worth $45,390,000 after acquiring an additional 48,207 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Analysts Set New Price Targets

ADUS has been the topic of a number of research analyst reports. Wall Street Zen raised Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research report on Monday, February 23rd. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research note on Wednesday. KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday. Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, January 21st. Finally, TD Cowen reaffirmed a “buy” rating on shares of Addus HomeCare in a research report on Wednesday, November 5th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $134.33.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.